Reaction
Heart Transplant reporting signals
As of the last recalculation, Heart Transplant appears in 887 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is TAFAMIDIS (PRR 85.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tafamidis | 41 | 85.6 | 85.9 |
| Bosentan | 80 | 40.8 | 40.9 |
| Sildenafil Powder, | 56 | 39.3 | 39.4 |
| Sildenafil | 73 | 32.1 | 32.2 |
| Dabigatran Etexilate Mesylate | 85 | 30.3 | 30.3 |
| Dabigatran Etexilate | 87 | 29.0 | 29.1 |
| Eplerenone | 15 | 27.9 | 28.0 |
| Mesna Injection | 9 | 25.8 | 25.8 |
| Mesna | 9 | 25.3 | 25.4 |
| Phytonadione | 9 | 25.1 | 25.2 |
| Heparin Sodium | 13 | 22.5 | 22.5 |
| Glecaprevir And Pibrentasvir | 10 | 21.6 | 21.6 |
| Granisetron Hydrochloride | 9 | 20.4 | 20.4 |
| Granisetron | 9 | 20.3 | 20.3 |
| Atropine | 7 | 20.0 | 20.0 |
| Sildenafil Citrate | 93 | 19.0 | 19.0 |
| Epoprostenol | 10 | 18.1 | 18.1 |
| Tobramycin Solution | 9 | 17.8 | 17.8 |
| Tobramycin Sulfate | 9 | 17.2 | 17.2 |
| Mycophenilic Acid | 14 | 16.1 | 16.1 |
| Sirolimus | 9 | 15.8 | 15.8 |
| Palivizumab | 10 | 15.4 | 15.4 |
| Atovaquone | 5 | 14.7 | 14.7 |
| Busulfan | 9 | 13.5 | 13.6 |
| Agalsidase Beta | 5 | 12.8 | 12.8 |
| Ambrisentan | 63 | 12.7 | 12.7 |
| Alteplase | 8 | 12.6 | 12.6 |
| Macitentan | 34 | 11.9 | 11.9 |
| Selexipag | 12 | 11.0 | 11.0 |
| Tobramycin | 10 | 9.9 | 9.9 |